XML 28 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Shareholders' Equity (Deficiency) - USD ($)
$ in Thousands
Total
Common Shares
Options
Accumulated other comprehensive (loss) income
Accumulated Deficit
Non-controlling interests
Warrant
Balance, Shares at Mar. 12, 2019   0          
Balance, Amount at Mar. 12, 2019 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Statement [Line Items]              
Common Shares Issued, Shares   23,331,000          
Common Shares Issued, Amount 1,400 $ 1,400          
Options Issued 86   86        
Warrants Issued 21           21
Common Shares Issued For Business Combinations 9         9  
Other Comprehensive Loss Exchange Differences On Foreign Operations 23     23      
Net Loss Attributable To Flora (2,844)       (2,824) (20)  
Balance, Shares at Dec. 31, 2019   23,331,000          
Balance, Amount at Dec. 31, 2019 (1,305) $ 1,400 86 23 (2,824) (11) 21
Statement [Line Items]              
Warrants Issued 0            
Other Comprehensive Loss Exchange Differences On Foreign Operations 16     16      
Net Loss Attributable To Flora (14,334)       (14,170) (164)  
Regulation A Offering, Shares   13,333,000          
Regulation A Offering, Amount 30,000 $ 25,605         4,395
Share Issuance Costs, Amount (3,107) $ (2,652)         (455)
Common Shares Issued For Services, Shares   1,333,000          
Common Shares Issued For Services, Amount 2,560 $ 2,560          
Common Shares Issued For Business Combinations, Shares   158,000          
Common Shares Issued For Business Combinations, Amount 49 $ 304     (317) 62  
Options Exercised, Shares   200,000          
Options Exercised, Amount 30 $ 37 (7)        
Options Issued, Amount 2,341   2,341        
Options Expired, Amount     (24)   24    
Balance, Shares at Dec. 31, 2020   38,355,000          
Balance, Amount at Dec. 31, 2020 16,250 $ 27,254 2,396 39 (17,287) (113) 3,961
Statement [Line Items]              
Warrants Issued 8,706            
Common Shares Issued For Business Combinations 2,507            
Other Comprehensive Loss Exchange Differences On Foreign Operations (1,147)     (1,147)      
Net Loss Attributable To Flora (21,361)       (21,249) (112)  
Common Shares Issued For Business Combinations, Shares   4,557,000          
Common Shares Issued For Business Combinations, Amount 20,654 $ 20,654          
Options Exercised, Shares   650,000          
Options Exercised, Amount 97 $ 121 (24)        
Options Issued, Amount 1,340   1,340        
November Unit Offering (notes 16 And 18), Shares   11,500,000          
November Unit Offering (notes 16 And 18), Amount 34,500 $ 25,794         8,706
November Unit Offering Issuance Costs (notes 16 And 18) (2,665) $ (3,720)         1,055
Initial Public Offering (note 16), Shares   3,333,000          
Initial Public Offering (note 16), Amount 16,667 $ 16,667          
Initial Public Offering Issuance Costs (notes 16 And 18), Shares   333,000          
Initial Public Offering Issuance Costs (notes 16 And 18), Amount (1,825) $ (3,145)         1,320
Regulation A And Other Offerings (note 16), Shares   55,000          
Regulation A And Other Offerings (note 16), Amount 157 $ 157          
Common Shares Issued For Investments, Shares   225,000          
Common Shares Issued For Investments, Amount 2,507 $ 2,507          
Warrants Exercised, Shares   6,509,000          
Warrants Exercised, Amount 13,353 $ 17,422         (4,069)
Warrants Expired/cancelled, Amount   303         (303)
Other Eqyuity Issuance Costs (1,586) $ (1,586)          
Balance, Shares at Dec. 31, 2021   65,517,000          
Balance, Amount at Dec. 31, 2021 $ 76,941 $ 102,248 $ 3,712 $ (1,108) $ (38,536) $ (225) $ 10,670